Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Monday, October 26, 2026

A Mouse is Not a Microscope: Digital Pathology Waiting for Quantum Leap in User Devices

›
Header:   Should digital pathology have a true revolution in the quality of input devices? ### Recently, we blogged about how digital pathol...
Sunday, October 25, 2026

Version 2: CMS, NIH, FDA Websites Switching to "SUPER INTELLIGENCE"

›
VERSION TWO - SUPER INTELLIGENCE The original version of this blog discussed government websites switching to "SUPER INTELLIGENCE"...

Version One; It's Here, It's Now: CMS, NIH, FDA Websites Switching to "SUPER INTELLIGENCE"

›
This summary is not available. Please click here to view the post.
Saturday, October 24, 2026

PAMA Unveils Bizarre Patterns for US Lab Test Pricing

›
Here's an analysis run mostly by AI, based on my ability to "vibe code" instructions of what AI had to do with raw PAMA Excel ...

CMS New Voluntary Exclusion Authority: What Court Cases Have Said

›
This month, RFK Jr gave CMS itself the elective exclusion authority long reserved only for referral to the OIG's attorneys. Blog . Here ...

Dr. Oz Videos: (#1) Hates Lab Industry, (#2) Deep Dive on Fraud, Documentary

›
HEADER Dr. Oz’s recent and biting criticism of laboratory pricing and CMS’s unusual fraud documentary reveal an increasingly aggressive agen...
Thursday, October 22, 2026

Speeding Up Digital Pathology: Great Lessons from Adoption of Da Vinci Robotic Surgery

›
 We often hear that adoption of digital pathology (since, for example, the $100M acquisition of Bioimagene by Roche almost twenty years ago)...
Wednesday, October 21, 2026

Cologuard 2.0 - Pricing on Earnings Call - Screen Shots from CMS

›
On the October 21, 2026, Abbott earnings call, there were some remarks on the pricing of Cologuard 2.0 in 2027 and forward. I'll  show t...

Using AI to Search Pub Med

›
We often hear the first step in learning to use AI, is using it as a big powerful kind of Google. I find AI can often work as a "big po...

An Early View: Stakeholders Respond to FDA's Concept Paper on LLM-SAMD

›
One brick at a time, FDA has been advancing LLM-based SAMD.  See the approval of draft-report software for ultraound and see the breakthrou...
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.